Last reviewed · How we verify
Convalescent Plasma from COVID-19 donors
Convalescent Plasma from COVID-19 donors is a Biologic drug developed by Fundacion Arturo Lopez Perez. It is currently in Phase 2 development.
At a glance
| Generic name | Convalescent Plasma from COVID-19 donors |
|---|---|
| Sponsor | Fundacion Arturo Lopez Perez |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Intermediate IND Severe Illness COVID-19 CP (PHASE1)
- Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients (PHASE2)
- Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection (NA)
- Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19 (PHASE3)
- Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients (NA)
- Convalescent Plasma for COVID-19 Patients (CPCP) (PHASE1)
- Efficacy and Safety of COVID-19 Convalescent Plasma (NA)
- Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Convalescent Plasma from COVID-19 donors CI brief — competitive landscape report
- Convalescent Plasma from COVID-19 donors updates RSS · CI watch RSS
- Fundacion Arturo Lopez Perez portfolio CI
Frequently asked questions about Convalescent Plasma from COVID-19 donors
What is Convalescent Plasma from COVID-19 donors?
Convalescent Plasma from COVID-19 donors is a Biologic drug developed by Fundacion Arturo Lopez Perez.
Who makes Convalescent Plasma from COVID-19 donors?
Convalescent Plasma from COVID-19 donors is developed by Fundacion Arturo Lopez Perez (see full Fundacion Arturo Lopez Perez pipeline at /company/fundacion-arturo-lopez-perez).
What development phase is Convalescent Plasma from COVID-19 donors in?
Convalescent Plasma from COVID-19 donors is in Phase 2.